Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

List of Tables

The lung cancer screening market size is expected to grow from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030; it is estimated to record a CAGR of 8.2% from 2022 to 2030.

The lung cancer screening market growth is attributed to the rising lung cancer Incidence and increasing government support. However, the high cost of lung screening tests is hampering the growth of the lung cancer screening market.

Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

Rising Government Supportis Boosting The Growth Of The Lung Cancer Screening Market

The United States Preventive Services Task Force recommends people aged 55-80 with a 30-pack-year (equivalent to smoking 20 cigarettes per day for 30 years) smoking history who are presently smoking or have quit within the last 15 years to undergo annual low-dose computed tomography (LDCT) screening for lung cancer.

As per the Cancer Australia 2023 report, lung cancer is the most common form of cancer in Australia, accounting for the majority of the mortality rates. Furthermore, early detection of lung cancer helps improve survival rates. Also, the new screening program will help detect lung cancer during the early stages when treatment is not likely to be successful. For example, in July 2021, Cancer Australia partnered with the Department of Health and Aged Care to determine the feasibility of a lung cancer screening program in Australia.

Such rising government support, policies, and approvals by several governments are boosting the growth of the lung cancer screening market.

Lung Cancer Screening Market - Cancer Type Insights

Based on cancer type, the lung cancer screening market is bifurcated into NSCLC and small cell lung cancer. The NSCLC segment accounted for the largest market share in 2022 and is expected to grow at a CAGR of 10.3% during the forecast period. The market position of this segment is due to the rising cases of NSCLC over the globe. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for approximately 10-15% of all NSCLC diagnoses.

Lung Cancer Screening Market - Technology Insights

Based on technology, the Lung cancer screening market is segmented into LDCT, chest X-ray, liquid biopsy, and others. The LDCT accounted for the largest market share in 2022 and same is expected to grow at a CAGR of 8.0% during the forecast period.

Lung Cancer Screening Market - Age Group Insights

Based on age group, the lung cancer screening market is bifurcated into 50 & older and below 50. The 50 & older segment accounted for the largest market share in 2022, however, the below 50 is expected to grow at a CAGR of 8.9% during the forecast period.

Lung Cancer Screening Market - End User Insights

Based on end user, the lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment accounted for the largest market share in 2022, however, the others is expected to grow at a CAGR of 8.7% during the forecast period.

Lung Cancer Screening Market - Recent Developments:

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:

In November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies are seeking to address one of the largest challenges in diagnosing lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.

In May 2021, Genetron Holdings Limited has partnered with Siemens Healthineers at the China Medical Equipment Fair. This partnership aims to promote the large-scale application of Genetron's S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals to provide non-small cell lung cancer (NSCLC) patients with efficient and accurate personalized diagnosis and treatment guidance.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the lung cancer screening market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the lung cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00029996

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Lung Cancer Screening Market - by Technology
- 1.3.2 Global Lung Cancer Screening Market - by Cancer Type
- 1.3.3 Global Lung Cancer Screening Market - by Age Group
- 1.3.4 Global Lung Cancer Screening Market - by End User
- 1.3.5 Global Lung Cancer Screening Market - by Geography

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Lung Cancer Screening Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis
4.3 Expert's Opinion

5. Lung Cancer Screening Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Lung Cancer Incidences
- 5.1.2 Increasing Government Support
5.2 Market Restraints
- 5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
- 5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
- 5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis

6. Lung Cancer Screening Market - Global Analysis

6.1 Global Lung Cancer Screening Market Revenue Forecast and Analysis
6.2 Global Lung Cancer Screening Market, by Geography - Forecast and Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

7.1 Overview
7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
- 7.3.1 Overview
- 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
- 7.4.1 Overview
- 7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Lung Cancer Screening Market Analysis - by Technology

8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
- 8.2.1 Overview
- 8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
- 8.3.1 Overview
- 8.3.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
- 8.4.1 Overview
- 8.4.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Lung Cancer Screening Market Analysis - by Age Group

9.1 Overview
9.2 & Older
- 9.2.1 Overview
- 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
- 9.3.1 Overview
- 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Lung Cancer Screening Market Analysis - by End User

10.1 Overview
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

11.1 North America: Lung Cancer Screening Market
- 11.1.1 Overview
- 11.1.2 North America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.3 North America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.1.4 North America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.1.5 North America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.1.6 North America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.1 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.1 Overview
    - 11.1.6.1.2 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.3 US: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.1.4 US: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.5 US: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.1.6 US: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.1 Overview
    - 11.1.6.2.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.3 Canada: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.2.4 Canada: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.5 Canada: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.2.6 Canada: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.3 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.1 Overview
    - 11.1.6.3.2 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.3 Mexico: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.3.4 Mexico: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.5 Mexico: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.3.6 Mexico: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: Lung Cancer Screening Market
- 11.2.1 Overview
- 11.2.2 Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.3 Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.2.4 Europe: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.2.5 Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.2.6 Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.1 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.1 Overview
    - 11.2.6.1.2 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.3 Germany: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.1.4 Germany: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.5 Germany: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.1.6 Germany: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.1 Overview
    - 11.2.6.2.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.3 UK: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.2.4 UK: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.5 UK: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.2.6 UK: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.3 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.1 Overview
    - 11.2.6.3.2 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.3 France: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.3.4 France: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.5 France: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.3.6 France: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.4 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.1 Overview
    - 11.2.6.4.2 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.3 Italy: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.4.4 Italy: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.5 Italy: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.4.6 Italy: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.5 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.1 Overview
    - 11.2.6.5.2 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.3 Spain: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.5.4 Spain: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.5 Spain: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.5.6 Spain: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.6 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.1 Overview
    - 11.2.6.6.2 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.3 Rest of Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.6.4 Rest of Europe: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.5 Rest of Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.6.6 Rest of Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3 Asia-Pacific: Lung Cancer Screening Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.3 Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.1 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.1 Overview
    - 11.3.6.1.2 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.3 China: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.1.4 China: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.5 China: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.1.6 China: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.1 Overview
    - 11.3.6.2.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.3 Japan: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.2.4 Japan: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.5 Japan: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.2.6 Japan: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.3 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.1 Overview
    - 11.3.6.3.2 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.3 India: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.3.4 India: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.5 India: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.3.6 India: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.4 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.1 Overview
    - 11.3.6.4.2 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.3 Australia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.4.4 Australia: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.5 Australia: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.4.6 Australia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.5 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.1 Overview
    - 11.3.6.5.2 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.3 South Korea: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.5.4 South Korea: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.5 South Korea: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.5.6 South Korea: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.6 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.1 Overview
    - 11.3.6.6.2 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.3 Rest of Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.6.4 Rest of Asia Pacific: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.5 Rest of Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.6.6 Rest of Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: Lung Cancer Screening Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.3 Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
  - 11.4.5.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.2.1 Overview
    - 11.4.5.2.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.2.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.2.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.2.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.2.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.3 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.3.1 Overview
    - 11.4.5.3.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.3.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.3.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.3.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.3.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.4 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.4.1 Overview
    - 11.4.5.4.2 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.4.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.4.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.4.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.4.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.5 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.5.1 Overview
    - 11.4.5.5.2 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.5.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.5.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.5.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.5.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: Lung Cancer Screening Market
- 11.5.1 Overview
- 11.5.2 South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.3 South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.5.5 South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.1 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.1 Overview
    - 11.5.6.1.2 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.3 Brazil: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.1.4 Brazil: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.5 Brazil: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.1.6 Brazil: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.1 Overview
    - 11.5.6.2.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.3 Argentina: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.2.4 Argentina: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.5 Argentina: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.2.6 Argentina: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.3 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.1 Overview
    - 11.5.6.3.2 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.3 Rest of South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.3.4 Rest of South & Central America: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.5 Rest of South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.3.6 Rest of South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

12.1 Impact Analysis of COVID-19 Pandemic on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

13.1 Recent Growth Strategies
- 13.1.1 Overview

14. Company Profiles

14.1 Intelerad Medical Systems
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Nuance Communications Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GE HealthCare
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Medtronic
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Canon Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Koninklijke Philips NV
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Siemens AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 CVS Health
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 bioAffinity Technologies, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 LungLife AI, Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms